Pharmacovigilance Strategies Workshop

Engage in the sharing of good practices between industry representatives and seek advice from regulators in this unique workshop

Back to Agenda

Session 6: Public and Patient Involvement in Pharmacovigilance

Session Chair(s)

Wendy Huisman, PharmD

Director

Vigifit, Netherlands

Bianca Mulder, PharmD, MPharm, MSc

Pharmacovigilance Assessor

Medicines Evaluation Board, Netherlands

Patient involvement is increasing in more areas of pharmacovigilance. What influence can patient representatives have on decision making? What is the influence of the public by for example social and regular media? How did public involvement influence the communication on the Covid vaccines. Can we ethically “use” influencers/social media as pharmaceutical industry?

Speaker(s)

Social Media on the Communication of Pfizer on COVID Vaccines

Ihsene Salaa-Lebcira, PhD, MPharm

Pfizer, France

Head of Safety Unit in France

Patient Perspective

Virginie Hivert, PharmD, PhD

Eurordis-Rare Diseases Europe, France

Therapeutic Development Director

Have an account?